Increase of GII.17 Norovirus Infections During the 2024–2025 Season in Multiple Cities, China
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Wenjing Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Biomedical Sciences, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Norovirus, Caliciviridae Infections, Genotype, Gastroenteritis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Science and Technology Major Projects for Significant New Drug Development of China.
Abstract (Originalsprache)
A significant numerical increase of genotype GII.17 norovirus‐associated sporadic infections was observed in multiple cities in China during the 2024–2025 season. We collected fecal samples from hospitalized children with acute gastroenteritis from 29 sentinel hospitals nationwide to screen for norovirus. A total of 18.7% ( n = 412) of the samples tested positive, with a decrease in genotype GII.4 (27% of all positive cases) coinciding with an increase in GII.17 (62%). Comparative phylogenetic analysis of RNA‐dependent RNA polymerase and capsid gene sequences revealed that these GII.17[P17] strains were most closely related to strains circulating in the United States and European countries during 2023–2024, with which they shared a recent common ancestor. The evolving epidemiology of norovirus, characterized by the circulation of multiple genotypes, highlights the need for ongoing surveillance and research to better understand its impact and guide the development of vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
- Shanghai Institute of Infectious Disease and Biosecurity, Key Laboratory of Medical Molecular Virology of MoE&MoH, Shanghai Medical College, Fudan University, Shanghai, China.
- Intelligent Medical Institute, Fudan University, Shanghai, China.
- Institute of Clinical Science, Clinical Center of Biotherapy, Zhongshan Hospital, Shanghai Institute of Infectious Disease and Biosecurity, Intelligent Medicine Institute, Shanghai Medical College, Fudan University, Sha…
ORCID-Profile: Wenjing Zheng
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Science and Technology Major Projects for Significant New Drug Development of China
Zitieren
APA
Zheng, W., Mu, X., Wang, S., Qiu, T., & Wang, X. (2026). Increase of GII.17 Norovirus Infections During the 2024–2025 Season in Multiple Cities, China. Journal of Medical Virology. https://doi.org/10.1002/jmv.70858
Vancouver
Zheng W, Mu X, Wang S, Qiu T, Wang X. Increase of GII.17 Norovirus Infections During the 2024–2025 Season in Multiple Cities, China. Journal of Medical Virology. 2026. doi:10.1002/jmv.70858
BibTeX
@article{Zheng2026,
author = {Zheng, Wenjing and Mu, Xinyue and Wang, Shaoyan and Qiu, Tianyi and Wang, Xuanyi},
title = {Increase of GII.17 Norovirus Infections During the 2024–2025 Season in Multiple Cities, China},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70858}
}
EUVIMED